Researcher.Life Logo

Biosafety and Health : Impact Factor & More

eISSN: 2590-0536
JournalOpen Access

Key Metrics

CiteScore
4
SJR
Q4Biotechnology
SNIP
1
Recommended pre-submission checks
Powered by Paperpal by Editage

Topics Covered on Biosafety and Health

Biosafety and Health Journal Specifications

Indexed in the following public directories

  • Web of Science Web of Science
  • Scopus Scopus
  • DOAJ DOAJ
  • SJR SJR
Overview
Publisher Elsevier
Language English
Article Processing ChargesUSD 2500
Publication Time9
Editorial Review ProcessBlind peer review
General Details
LanguageEnglish
Society/Institute/SponsorChinese Medical Association; National Institute for Viral Disease Control and Prevention, Chinese Center for Disease Control and Prevention (China CDC)
Website URLVisit website
Publication Details
PlagiarismVisit website
Publication Time 9
Waiver PolicyVisit website
Editorial Review Detail
Editorial TeamVisit website
Review ProcessBlind peer review
Review UrlVisit website
Information for authors
Author instructionsVisit website
Copyright DetailsVisit website
License typeCC BY, CC BY-NC-ND
OA statementVisit website
View less

Planning to publish in Biosafety and Health ?

Upload your Manuscript to get

  • Degree of match
  • Common matching concepts
  • Additional journal recommendations
Free Report

Recently Published Papers in Biosafety and Health

Beyond antibiotics: Multidimensional interventions and coordinated governance against ESKAPE resistance
  • 1 Mar 2026
  • Biosafety and Health
Genomic analysis of MCR-8 and NDM-5 coproducing Klebsiella pneumoniae, an important ESKAPE pathogen, isolated from an ICU inpatient from a tanker explosion incident
  • 1 Mar 2026
  • Biosafety and Health
Shifting seasonal patterns of influenza before, during and after the COVID-19 pandemic in Shanghai, China: A population-based surveillance study, 2015–2023
  • 1 Mar 2026
  • Biosafety and Health
A landscape of epidemiology and strain distribution of Nocardia in China
  • 1 Mar 2026
  • Biosafety and Health
Impact of adjuvants on a recombinant SARS-CoV-2 spike vaccine: Protective efficacy and recall antibody response following homologous challenge.
  • 1 Feb 2026
  • Biosafety and health
A semi-mechanistic modeling strategy for infectious diseases forecasting: Error correction and probabilistic prediction.
  • 1 Feb 2026
  • Biosafety and health
Beyond antibiotics: Multidimensional interventions and coordinated governance against ESKAPE resistance
  • 1 Mar 2026
  • Biosafety and Health
Genomic analysis of MCR-8 and NDM-5 coproducing Klebsiella pneumoniae, an important ESKAPE pathogen, isolated from an ICU inpatient from a tanker explosion incident
  • 1 Mar 2026
  • Biosafety and Health
Shifting seasonal patterns of influenza before, during and after the COVID-19 pandemic in Shanghai, China: A population-based surveillance study, 2015–2023
  • 1 Mar 2026
  • Biosafety and Health
A landscape of epidemiology and strain distribution of Nocardia in China
  • 1 Mar 2026
  • Biosafety and Health
Impact of adjuvants on a recombinant SARS-CoV-2 spike vaccine: Protective efficacy and recall antibody response following homologous challenge.
  • 1 Feb 2026
  • Biosafety and health
A semi-mechanistic modeling strategy for infectious diseases forecasting: Error correction and probabilistic prediction.
  • 1 Feb 2026
  • Biosafety and health

FAQs on Biosafety and Health